维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="NASLUND M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Appetite signaling: From gut peptides and enteric nerves to brain显示文摘	Naslund E Hellstrom P M	2007	Physiology and Behavior2007，92，12：	1
2	Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men显示文摘	Naslund M Eaddy MT Kruep EJ	2008	The American journal of managed care2008，14，5：	1
3	Nanoscale alloying,phase-segregation,and core-shell evolution of gold-platinum nanoparticles and their electrocatalytic effect on oxygen reduction reaction显示文摘	WANJALA B N LUOJ LOUKRAKPAM R FANG B MOTT D NJOKI PN ENGELHARD M NASLUND H R WUJK WANGL MALIS O ZHONG C J	2010	Chem Mater2010，22，14：	1
4	A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate显示文摘	Naslund M J Miner M	2007	Clin Ther2007，29，1：	1
5	Localization and effects of orexin on fasting motility in the rat duodenum显示文摘	Naslund E Ehrstrom M Ma J	2002	Am J Physiol Gastrointest Liver Physiol2002，282，：	1
6	The role of androgens and etrogens in the pathogenesis of experimental nonbacterial prostatitis显示文摘	NASLUND M J STRANDBERG JD COFFEY DS	1988	J Urol1988，40，5：	1
7	A review of the clinical efficacy and safety of 5'alpha - reductase inhibitors for the enlarged prostate显示文摘	Naslund M J Miner M	2007	Clin Ther2007，29，1：	1
8	Complications after radical retropubic prostaetctomy in the medicare population显示文摘	Benoit RM Naslund M J Cohen JK	2000	J Biol chen2000，56，：	1
9	Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus显示文摘	Naslund J Lagerqvist N Habjan M	2009	Virology2009，385，2：	1
10	Vaccination with vi- rus-like particles protects mice from lethal infection of Rift Valley Fever Virus显示文摘	Naslund J Lagerqvist N Habjan M	2009	Virology2009，385，2：	1
11	Ilvaite, an alteration product replacing olivine in the Skaergaard intrusion 显示文摘	Naslund H R Hughes J M Bimie R W	1983	Mineral1983，68，：	1
12	A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate显示文摘	Naslund MJ Miner M	2007	Clin Ther2007，29，：	1
13	Complications after radical retropubic prostatectomy in the medicare population显示文摘	Benoit R M Naslund M J Cohen J K	2000	Urology2000，56，1：	1
14	A review of the clinical efficacy and safety of 5α-reductase inhibitors for the enlarged prostate显示文摘	Naslund M J Miner M	2007	ClinTher2007，29，1：	1
15	Appetite signaling: from gut pepfides and enteric nerves to brain显示文摘	NaSLUND E HELLSTROM P M	2007	Physiology and Behavior2007，92，12：	1
16	Localization and effects of Orexin on fasting motility in the rat duodenum显示文摘	Naslund E Ehrstrom M	2002	Am J Physiol Gastrointest Liver Physiol2002，282，：	1
17	Prevalence of lower urinary tract symp toms and prostate enlargement in the primary care setting显示文摘	Naslund M J Gilsenan A W Midkiff K D	2007	Int J Clin Pract2007，61，9：	1
18	Lactoferrin inhibits human papillomavims binding and uptake in vitro显示文摘	Drobni P Naslund J Evander M	2004	Antivir Ther2004，64，：	1
19	Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare- aged men显示文摘	NASLUND M EADDY MT KRUEP EJ	2008	Am J Manag Care2008，14，52：	1
20	A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate显示文摘	Naslund M J Miner M	2007	Clin Yher2007，29，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示